iBio (IBIO) Current Assets (2011 - 2026)

iBio (IBIO) has reported Current Assets for 16 consecutive years, with $92.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets rose 848.68% year-over-year to $92.2 million in Q2 2026; TTM through Jun 2026 was $92.2 million, a 848.68% increase from a year earlier, with the FY2026 full-year figure at $92.2 million, up 848.68% from the prior year.
• Current Assets was $92.2 million for Q2 2026 at iBio, up from $77.3 million in the prior quarter.
• Over five years, Current Assets peaked at $92.2 million in Q2 2026 and troughed at $6.1 million in Q1 2025.
• A 5-year average of $36.9 million and a median of $31.6 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets plunged 83.12% in 2025 and surged 1167.21% in 2026, its largest moves.
• Over 5 years, Current Assets stood at $38.2 million in 2022, then tumbled by 48.48% to $19.7 million in 2023, then slumped by 57.87% to $8.3 million in 2024, then jumped by 543.37% to $53.4 million in 2025, then soared by 72.7% to $92.2 million in 2026.
• The last three Current Assets figures came in at $92.2 million (Q2 2026), $77.3 million (Q1 2026), and $53.4 million (Q4 2025), per Business Quant data.